Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents.
about
The rational patient and beyond: implications for treatment adherence in people with psychiatric disabilitiesAssociation between depression and neuropathy in people with type 2 diabetes: a meta-analysis.Occurrence and Predictors of Depression and Poor Quality of Life among Patients with Type-2 Diabetes: A Northern India PerspectiveHow to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus.Prevalence of depression and associated risk factors among persons with type-2 diabetes mellitus without a prior psychiatric history: a cross-sectional study in clinical settings in urban NepalDepression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysisDepression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severityCharacteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disordersThe relationship between depressive symptoms and medication nonadherence in type 2 diabetes: the role of social supportEffectiveness of a multifactorial cardiovascular risk reduction clinic for diabetes patients with depressionMedication taking and diabetes: a systematic review of the literature.Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes.An audit of viral load in one clinical population to describe features of viraemic patients on antiretroviral therapy.Comparative study of the influence of diabetes distress and depression on treatment adherence in Chinese patients with type 2 diabetes: a cross-sectional survey in the People's Republic of China.Changes in diabetes distress related to participation in an internet-based diabetes care management program and glycemic control.Adherence with migraine prophylaxis in clinical practice.Positive association between serious psychiatric outcomes and complications of diabetes mellitus in patients with depressive disorders.Too much of a good thing? Overexertion of self-control and dietary adherence in individuals with Type 2 diabetes.Longitudinal effects of medication nonadherence on glycemic control.Regional, Geographic, and Ethnic Differences in Medication Adherence Among Adults with Type 2 Diabetes.Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes.The role of cognitive impairment and caregiver support in diabetes management of older outpatients.Mediators of adherence among adults with comorbid diabetes and depression: The role of self-efficacy and social support.Associations among medication regimen complexity, medical specialty, and medication possession ratio in newly diagnosed hypertensive patients: A population-based study.Effects of depression and antidepressant use on goal setting and barrier identification among patients with type 2 diabetes.Daytime sleepiness, diabetes, and psychological well-being.Negative affect differentiation and adherence during treatment for thalassemia.Determinants of adherence to diabetes treatment.An observational study examining the effect of comorbidity on the rates of persistence and adherence to newly initiated oral anti-hyperglycaemic agents.
P2860
Q26864657-364E1883-FA9C-454C-8D4C-465CA94803C5Q30251984-7340DE25-1B0B-44FA-9F21-297515B3DAFEQ33815531-53DD42F9-DA57-46DE-90E9-36BBCA92570CQ34344393-DA8B0469-7D12-4D8D-9EA0-B28C3FA9BB25Q35044632-E17C39CF-00B1-4FF8-A23E-6CAF960A83F7Q35235484-2F959E3A-6BD2-4B03-A874-36CDA824BDDAQ35634792-E3D121D5-0E50-44B3-B6EF-96BA206593C5Q35649045-ACE6BBD0-4B6C-46A0-9070-9A8ED0824554Q35936047-63F06DD4-6C66-4111-A98E-A785C65C8F76Q36962506-D3871681-84E5-4AF4-8DB4-A2E67EC96FC7Q37023520-586074C0-3558-4EB1-8E33-64C3EFCF1C0FQ37082944-8D570ABA-30E0-43AE-BFE0-D9DD4F4C9A30Q37094002-8A0F1438-E272-4B51-8F73-D817462F134BQ37165174-6A97A31A-BFD1-4D06-A765-88B6C6913686Q37404371-A849BB2C-475E-4077-AF26-D06937BF42E7Q38434618-36A02350-4659-4940-930F-15108885B0AEQ38583648-218445E0-3C03-401C-81FD-9CDA851E9190Q38883592-D7B84199-9025-4283-9EBD-1350F6412F06Q39241507-582EA582-0989-4366-916E-3CD7F16395C2Q39970034-EE771114-B3F3-4C8D-AB12-CDD8B49C2FECQ43142540-9BF6657F-03D5-41D2-BA03-C7D1EC918349Q45974502-4384BEEE-4F06-45E6-8CBC-A6490CA95E20Q46900674-B01D7751-7A9C-4BC6-927A-FC161375AD20Q47107367-7423CE7D-79D5-4A93-BDFA-52F15A4D2FD2Q48144436-044AC5AF-1CB7-4EE2-8649-5B8EE91C331FQ48320766-592E7E8A-B9D7-4F6A-9AF9-20B219C19FD0Q50552136-F52C9AC4-41F9-46CE-99F2-A8D2A19DE61EQ53644240-88359793-28E1-4732-93BF-EA03276898E7Q54723004-93CF1FA9-242D-4923-8109-F35C557F8B10
P2860
Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Depression in patients with ty ...... e to oral hypoglycemic agents.
@en
type
label
Depression in patients with ty ...... e to oral hypoglycemic agents.
@en
prefLabel
Depression in patients with ty ...... e to oral hypoglycemic agents.
@en
P2093
P2860
P356
P1476
Depression in patients with ty ...... e to oral hypoglycemic agents.
@en
P2093
Betsy L Meredith Elswick
Eugene H Makela
Iftekhar D Kalsekar
Mayur M Amonkar
Stratford M Douglas
Suresh S Madhavan
Virginia G Scott
P2860
P304
P356
10.1345/APH.1G606
P407
P577
2006-03-21T00:00:00Z